Overview
- Discusses in depth the potential of innovative methods in the broad field of glioma immunology and immunotherapy
- Useful for clinicians, clinical scientists and basic scientists
- Reviews the basic and clinical background, and proceeds from basic science at the bench to the bedside to give a realistic evaluation of the immunology and immunotherapy of glioma
- Written by internationally distinguished experts working in basic science and clinical neurooncology
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 746)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (17 chapters)
-
Front Matter
-
Basic and Clinical Aspects of Glioma
-
Front Matter
-
-
Glioma Immunology
-
Front Matter
-
-
Cytokine, Serotherapy, Adoptive Transfer And Other Strategies
-
Front Matter
-
-
Active Immunotherapy
-
Front Matter
-
Keywords
About this book
Reviews
From the reviews:
“This textbook is geared mostly toward the immune cell, and cytokine mediated treatment of gliomas in human patients. … I recommend this book enthusiastically to neurosurgeons and neurooncologists.” (Joseph J. Grenier, Amazon.com, June, 2014)Editors and Affiliations
About the editor
RYUYA YAMANAKA is now a Professor at Kyoto Prefectural University of Medicine, Kyoto, Japan. He earned his MD at Niigata University, Japan, in 1982 and completed a neurosurgical residency training at its affiliated hospitals. He received his academic degree (Dr Med Sci) from Niigata University. Following research fellowships at the National Institutes of Health in the United States from 1994 to 1998, he assumed the position of Assistant Professor and Lecturer at the Department of Neurosurgery in the Brain Research Institute at Niigata University. In 2006, he was promoted to Professor of the Research Center of Innovative Cancer Therapy at Kurume University School of Medicine. He joined the faculty at Kyoto Prefectural University of Medicine in 2010. His main research interests include translational biochemical research in clinical oncology, including brain tumors. He is a member of international and national scientific organizations, including the American Association for Cancer Research (AACR ), American Society of Clinical Oncology (ASCO), Japanese Cancer Association (JCA), Japanese Society of Medical Oncology (JSMO) and Japan Neurosurgical Society (JNS). He has board certifications for Medical Oncology, Neurosurgery, Stroke and Cerebrovascular Diseases.
Bibliographic Information
Book Title: Glioma
Book Subtitle: Immunotherapeutic Approaches
Editors: Ryuya Yamanaka
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-1-4614-3146-6
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2012
Hardcover ISBN: 978-1-4614-3145-9Published: 26 April 2012
Softcover ISBN: 978-1-4939-4439-2Published: 23 August 2016
eBook ISBN: 978-1-4614-3146-6Published: 27 May 2012
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: XIX, 232
Topics: Biomedicine general, Immunology, Cancer Research